Evidence map›Paper›PMID 38461463›Full record

ArticleAnnals of surgical oncology2024

The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors.

Stefano Partelli, Francesca Fermi, Giuseppe K Fusai, Domenico Tamburrino, Panagis Lykoudis, Nassiba Beghdadi, Safi Dokmak, Dominik Wiese, Luca Landoni, Federico Reich and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Hospital volume stratification using stratum-specific likelihood ratios for pancreatectomy.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Stefano Partelli *Pancreatic and Transplant Surgery Unit, Vita-Salute University, San Raffaele Hospital, Milan, Italy. partelli.stefano@hsr.it.
Francesca Fermi *Pancreatic and Transplant Surgery Unit, Vita-Salute University, San Raffaele Hospital, Milan, Italy.
Giuseppe K FusaiDepartment of HPB and Liver Transplant Surgery, Royal Free Hospital, London, UK.
Domenico TamburrinoPancreatic and Transplant Surgery Unit, Vita-Salute University, San Raffaele Hospital, Milan, Italy.
Panagis LykoudisDepartment of HPB and Liver Transplant Surgery, Royal Free Hospital, London, UK.
Nassiba BeghdadiDepartment of Hepato-Pancreato-Biliary Surgery, Pôle des Maladies de l'Appareil Digestif, Université de Paris-Paris Diderot, Beaujon Hospital, Clichy, France.
Safi DokmakDepartment of Hepato-Pancreato-Biliary Surgery, Pôle des Maladies de l'Appareil Digestif, Université de Paris-Paris Diderot, Beaujon Hospital, Clichy, France.
Dominik WieseDepartment of Visceral, Thoracic, and Vascular Surgery, Philipps University, Marburg, Germany.
Luca LandoniUnit of General and Pancreatic Surgery, University and Hospital Trust of Verona, Verona, Italy.
Federico ReichUnit of General and Pancreatic Surgery, University and Hospital Trust of Verona, Verona, Italy.
O R C BuschDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Niccolò NapoliDivision of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Jin-Young JangDepartment of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Wooil KwonDepartment of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Thomas ArmstrongDepartment of Surgery, University Hospital Southampton, Southampton, UK.
Peter J AllenDepartment of Surgery, Duke University School of Medicine, Division of Surgical Oncology, Duke Cancer Institute, Durham, NC, USA.
Jin HeDivision of Surgical Oncology, Surgical Oncology, Pathology and Oncology, Johns Hopkins Medical Institution, Baltimore, MD, USA.
Ammar JavedDepartment of Surgery, New York University Grossman School of Medicine and NYU-Langone Medical Center, New York, NY, USA.
Alain SauvanetDepartment of Hepato-Pancreato-Biliary Surgery, Pôle des Maladies de l'Appareil Digestif, Université de Paris-Paris Diderot, Beaujon Hospital, Clichy, France.
Detlef K BartschDepartment of Visceral, Thoracic, and Vascular Surgery, Philipps University, Marburg, Germany.
Roberto SalviaUnit of General and Pancreatic Surgery, University and Hospital Trust of Verona, Verona, Italy.
E J M Nieveen van DijkumDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Mark G BesselinkDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ugo BoggiDivision of General and Transplant Surgery, University of Pisa, Pisa, Italy.
Sun-Whe KimDepartment of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Christofer L WolfgangDepartment of Surgery, New York University Grossman School of Medicine and NYU-Langone Medical Center, New York, NY, USA.
Massimo FalconiPancreatic and Transplant Surgery Unit, Vita-Salute University, San Raffaele Hospital, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTextbook outcome (TO) is a composite variable that can define the quality of pancreatic surgery. The aim of this study is to evaluate TO after pancreatoduodenectomy (PD) for nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). PATIENTS AND

methodsAll patients who underwent PD for NF-PanNETs (2007-2016) in different centers were included in this retrospective study. TO was defined as the absence of severe postoperative complications and mortality, length of hospital stay ≤ 19 days, R0 resection, and at least 12 lymph nodes harvested.

resultsOverall, 477 patients were included. The TO rate was 32%. Tumor size [odds ratio (OR) 1.696; p = 0.013], a minimally invasive approach (OR 12.896; p = 0.001), and surgical volume (OR 2.062; p = 0.023) were independent predictors of TO. The annual frequency of PDs increased over time as well as the overall rate of TO. At a median follow-up of 44 months, patients who achieved TO had similar disease-free (p = 0.487) and overall survival (p = 0.433) rates compared with patients who did not achieve TO. TO rate in patients with NF-PanNET > 2 cm was 35% versus 27% in patients with NF-PanNET ≤ 2 cm (p = 0.044). Considering only NF-PanNETs > 2 cm, patients with TO and those without TO had comparable 5-year overall survival rates (p = 0.766)

conclusionsTO is achieved in one-third of patients after PD for NF-PanNETs and is not associated with a benefit in terms of long-term survival.

Indexed as

BenchmarkingPancreatic NeoplasmsPancreaticoduodenectomyPostoperative ComplicationsAdultAgedFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedNeuroendocrine TumorsPrognosisRetrospective StudiesSurvival RateLong-term survivalNonfunctioning pancreatic neuroendocrine tumorsPancreaticoduodenectomyPostoperative complicationsSurgical volumeTextbook outcome

Identifiers

PMID38461463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.